SK7342000A3 - Formulations comprising dissolved paroxetine - Google Patents
Formulations comprising dissolved paroxetine Download PDFInfo
- Publication number
- SK7342000A3 SK7342000A3 SK734-2000A SK7342000A SK7342000A3 SK 7342000 A3 SK7342000 A3 SK 7342000A3 SK 7342000 A SK7342000 A SK 7342000A SK 7342000 A3 SK7342000 A3 SK 7342000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- paroxetine
- solid
- capsules
- carrier
- capsule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9724544.3A GB9724544D0 (en) | 1997-11-21 | 1997-11-21 | Novel Formulation |
| PCT/GB1998/003471 WO1999026625A1 (en) | 1997-11-21 | 1998-11-18 | Formulations comprising dissolved paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK7342000A3 true SK7342000A3 (en) | 2000-12-11 |
Family
ID=10822374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK734-2000A SK7342000A3 (en) | 1997-11-21 | 1998-11-18 | Formulations comprising dissolved paroxetine |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1033986A1 (xx) |
| JP (1) | JP2001523718A (xx) |
| KR (1) | KR20010032320A (xx) |
| CN (1) | CN1279608A (xx) |
| AP (1) | AP2000001821A0 (xx) |
| AR (1) | AR015485A1 (xx) |
| AU (1) | AU1168099A (xx) |
| BG (1) | BG104527A (xx) |
| BR (1) | BR9814220A (xx) |
| CO (1) | CO4970832A1 (xx) |
| DZ (1) | DZ2658A1 (xx) |
| EA (1) | EA200000552A1 (xx) |
| GB (1) | GB9724544D0 (xx) |
| HU (1) | HUP0100580A3 (xx) |
| IL (1) | IL136106A0 (xx) |
| MA (1) | MA24704A1 (xx) |
| NO (1) | NO20002590L (xx) |
| OA (1) | OA11385A (xx) |
| PE (1) | PE20000381A1 (xx) |
| PL (1) | PL340555A1 (xx) |
| SK (1) | SK7342000A3 (xx) |
| TR (1) | TR200001423T2 (xx) |
| WO (1) | WO1999026625A1 (xx) |
| ZA (1) | ZA9810637B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9810180D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulation |
| EP1161241B1 (de) * | 1999-03-12 | 2005-12-07 | Aesica Pharmaceuticals Ltd. | Stabile pharmazeutische anwendungsform für paroxetin-anhydrat |
| DK1109806T3 (da) | 1999-07-01 | 2003-12-22 | Italfarmaco Spa | Komplekser af paroxetin med cyclodextriner eller cyclodextrinderivater |
| DE19930454A1 (de) * | 1999-07-02 | 2001-01-04 | Knoll Ag | Feste Paroxetin enthaltende Zubereitungen |
| US6720003B2 (en) | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
| ES2294197T3 (es) * | 2001-12-21 | 2008-04-01 | Supernus Pharmaceuticals, Inc. | Formulacion de capsula oral con estabilidad fisica aumentada. |
| SE0200475D0 (sv) * | 2002-02-15 | 2002-02-15 | Ltp Lipid Technologies Provide | Oral farmaceutisk beredning |
| WO2006119779A2 (en) * | 2005-05-10 | 2006-11-16 | Lifecycle Pharma A/S | A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
| JP2013512948A (ja) * | 2009-12-08 | 2013-04-18 | イル・ファ・カンパニー・リミテッド | ２０−Ｏ−β−Ｄ−グルコピラノシル−２０（Ｓ）−プロトパナキサジオールを含む固体分散体 |
| GB201020032D0 (en) * | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| CN103961333B (zh) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | 甲磺酸帕罗西汀胶囊及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9707585A (es) * | 1995-04-03 | 1997-12-31 | Abbott Lab | Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada. |
| NZ336587A (en) * | 1997-01-15 | 2001-01-26 | Smithkline Beecham P | Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran |
-
1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
-
1998
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/xx unknown
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/en not_active Application Discontinuation
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Application Discontinuation
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/xx active
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 EP EP98954631A patent/EP1033986A1/en not_active Withdrawn
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
-
2000
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999026625A1 (en) | 1999-06-03 |
| BG104527A (en) | 2001-04-30 |
| CO4970832A1 (es) | 2000-11-07 |
| HUP0100580A2 (hu) | 2002-04-29 |
| AR015485A1 (es) | 2001-05-02 |
| NO20002590L (no) | 2000-07-19 |
| TR200001423T2 (tr) | 2000-10-23 |
| PL340555A1 (en) | 2001-02-12 |
| EA200000552A1 (ru) | 2000-10-30 |
| KR20010032320A (ko) | 2001-04-16 |
| EP1033986A1 (en) | 2000-09-13 |
| HUP0100580A3 (en) | 2002-05-28 |
| DZ2658A1 (fr) | 2003-03-22 |
| OA11385A (en) | 2004-01-27 |
| BR9814220A (pt) | 2001-12-26 |
| AP2000001821A0 (en) | 2000-06-30 |
| CN1279608A (zh) | 2001-01-10 |
| GB9724544D0 (en) | 1998-01-21 |
| IL136106A0 (en) | 2001-05-20 |
| AU1168099A (en) | 1999-06-15 |
| PE20000381A1 (es) | 2000-05-07 |
| JP2001523718A (ja) | 2001-11-27 |
| NO20002590D0 (no) | 2000-05-19 |
| MA24704A1 (fr) | 1999-07-01 |
| ZA9810637B (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6524615B2 (en) | Controlled release pharmaceutical composition | |
| US6491950B1 (en) | Controlled release pharmaceutical composition | |
| US6372251B2 (en) | Formulations comprising lipid-regulating agents | |
| US8293270B2 (en) | Lipophilic vehicle-based dual controlled release matrix system | |
| CA2365128A1 (en) | Novel formulations comprising lipid-regulating agents | |
| SK7342000A3 (en) | Formulations comprising dissolved paroxetine | |
| US6838091B2 (en) | Formulations comprising lipid-regulating agents | |
| KR100679582B1 (ko) | 경질 쉘 캡슐용 이부프로펜 용액 | |
| KR20040006887A (ko) | 아세트아미노펜을 함유하는 제어방출성의 경구용 제제 | |
| US6814977B1 (en) | Formulations comprising lipid-regulating agents | |
| WO2021163023A1 (en) | Stable formulations of dronabinol | |
| US20020032220A1 (en) | Formulations comprising dissolved paroxetine | |
| US20040146537A1 (en) | Oily wax matrix suspension formulation comprising pharmacologically active agents | |
| US20020040046A1 (en) | Novel formulations comprising lipid-regulating agents | |
| CZ20001876A3 (cs) | Prostředky obsahující rozpuštěný paroxetin | |
| EP1183017A1 (en) | Novel formulations comprising lipid-regulating agents | |
| MXPA00005030A (en) | Formulations comprising dissolved paroxetine | |
| CA2310407A1 (en) | Formulations comprising dissolved paroxetine | |
| SI8710407A (sl) | Postopek za pridobivanje trdnega pripravka s podaljšanim sproščanjem aktivne spojine |